论文部分内容阅读
目的:探讨头孢唑林治疗产妇产褥期感染的临床疗效。方法:选取2014年1月到2015年1月我院收治的100例产褥期感染产妇,并将其随机均分成实验组和对照组。对照组产妇接受左氧氟沙星治疗,实验组患者在此基础上加之进行头孢唑林治疗,观察并对照两组的临床治疗效果和不良反应。结果:实验组产褥期感染产妇的治疗总有效率为98%,不良反应发生率为10%,对照组产褥期感染产妇的治疗总有效率为78%,不良反应发生率为12%,两组临床治疗效果差异显著具备统计学意义(P<0.05),不良反应发生率差异不具备统计学意义(P>0.05)。结论:头孢唑林在治疗产妇产褥期感染当中具有明显的治疗效果,能够提高临床疗效和抗感染成效,改善产妇血液指标,同时具备极高的安全性,值得临床推广。
Objective: To investigate the clinical effect of cefazolin on maternal puerperium infection. Methods: From January 2014 to January 2015, 100 cases of postpartum puerperal infection in our hospital were selected and randomly divided into experimental group and control group. The control group maternal levofloxacin treatment, the experimental group patients on the basis of this combined with cefazolin treatment, observation and control two groups of clinical treatment and adverse reactions. Results: In the experimental group, the total effective rate of puerperal infection was 98% and the adverse reaction rate was 10%. The total effective rate of puerperium infected women in control group was 78% and the adverse reaction rate was 12% The difference was statistically significant (P <0.05). The difference in adverse reactions was not statistically significant (P> 0.05). Conclusion: Cefazolin treatment of maternal puerperium infection has obvious therapeutic effect, which can improve clinical efficacy and anti-infective efficacy, improve maternal blood indicators, with high safety, it is worth to clinical promotion.